Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus - Université Paris Cité Accéder directement au contenu
Article Dans Une Revue ESMO Open Année : 2022

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

1 Universitätsklinikum Ulm - University Hospital of Ulm
2 Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
3 Imperial College London
4 Hammersmith Hospital NHS Imperial College Healthcare
5 Fondazione IRCCS Policlinico San Matteo [Pavia]
6 UNIPV - Università degli Studi di Pavia = University of Pavia
7 CESP - Centre de recherche en épidémiologie et santé des populations
8 CHV - Centre Hospitalier de Versailles André Mignot
9 Charité Campus Virchow-Klinikum (CVK)
10 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
11 Freie Universität Berlin
12 HU Berlin - Humboldt-Universität zu Berlin = Humboldt University of Berlin = Université Humboldt de Berlin
13 Medical Oncology Unit, Dept of Medical Oncology and Hematology [Fondazione IRCCS Istituto Nazionale Tumori, Milan]
14 UNIMI - Università degli Studi di Milano = University of Milan
15 IRCCS Milan - Istituto Clinico Humanitas [Milan]
16 NKUA - National and Kapodistrian University of Athens
17 UCLH - University College London Hospitals
18 NHS Foundation Trust [London]
19 WWU - Westfälische Wilhelms-Universität Münster = University of Münster
20 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
21 UniSR - Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie]
22 IRCCS Ospedale San Raffaele [Milan, Italy]
23 QMUL - Queen Mary University of London
24 Lékařská fakulta / Faculty of Medicine [University of Ostrava]
25 Medizinische Universität Wien = Medical University of Vienna
26 UPCité - Université Paris Cité
27 AP-HP - Hopital Saint-Louis [AP-HP]
28 University Hospital Hamburg-Eppendorf
29 CHU Nantes - Centre Hospitalier Universitaire de Nantes
30 University Hospital Basel [Basel]
31 Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
32 DEPT - Department of Physiopatology and Transplantation, University of Milan
33 IJC - Josep Carreras Leukaemia Research Institute
34 UAB - Universitat Autònoma de Barcelona = Autonomous University of Barcelona = Universidad Autónoma de Barcelona
35 MUL - Medical University of Łódź
36 Clínica Universidad de Navarra [Pamplona]
37 AOUC - Azienda Ospedaliero Universitaria Careggi [Firenze] = Careggi University Hospital [Florence, Italy]
38 UniFI - Università degli Studi di Firenze = University of Florence = Université de Florence
39 Jena University Hospital [Jena]
40 LMU - Ludwig Maximilian University [Munich] = Ludwig Maximilians Universität München
41 Leibniz Institute for Natural Product Research and Infection Biology (Hans Knoell Institute)
42 Uninsubria - Universitá degli Studi dell’Insubria = University of Insubria [Varese]
M. Dreyling
  • Fonction : Auteur
M.G. da Silva
  • Fonction : Auteur
M. Heuser
  • Fonction : Auteur
N. Kröger
G. Sanz
  • Fonction : Auteur
P. Sonneveld
  • Fonction : Auteur
G. Pentheroudakis
  • Fonction : Auteur

Résumé

Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance. Results and conclusion: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.

Domaines

Cancer
Fichier principal
Vignette du fichier
main.pdf (525.53 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03642597 , version 1 (03-05-2022)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

C. Buske, M. Dreyling, A. Alvarez-Larrán, J. Apperley, L. Arcaini, et al.. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus. ESMO Open, 2022, 7 (2), pp.100403. ⟨10.1016/j.esmoop.2022.100403⟩. ⟨hal-03642597⟩
34 Consultations
31 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More